Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602

Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602

Bibliographic Details
Main Authors: Sato, Yozo, Watanabe, Hirokazu, Sone, Miyuki, Onaya, Hiroaki, Sakamoto, Noriaki, Osuga, Keigo, Takahashi, Masahide, Arai, Yasuaki
Format: Online
Language:English
Published: Informa Healthcare 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572665/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572665/

Similar Items